UTILITY OF CYTOKERATIN IMMUNOSTAINING IN SEPARATING PULMONARY ADENOCARCINOMAS FROM COLONIC ADENOCARCINOMAS

Citation
Ts. Loy et Rd. Calaluce, UTILITY OF CYTOKERATIN IMMUNOSTAINING IN SEPARATING PULMONARY ADENOCARCINOMAS FROM COLONIC ADENOCARCINOMAS, American journal of clinical pathology, 102(6), 1994, pp. 764-767
Citations number
35
Categorie Soggetti
Pathology
ISSN journal
00029173
Volume
102
Issue
6
Year of publication
1994
Pages
764 - 767
Database
ISI
SICI code
0002-9173(1994)102:6<764:UOCIIS>2.0.ZU;2-J
Abstract
Adenocarcinomas of uncertain origin are a frequent problem for surgica l pathologists. To determine the utility of immunostaining for cytoker atin 7 and cytokeratin 20 in the separation of pulmonary adenocarcinom as from colonic adenocarcinomas, we studied routinely processed, forma lin-fixed tissue from 151 of these tumors using commercially available monoclonal antibodies and an avidin-biotin immunohistochemical techni que. Used alone, neither cytokeratin 7 immunostaining or cytokeratin 2 0 immunostaining reliably separated these tumors. However, the immunop henotype of cytokeratin 7 positive/cytokeratin 20 negative was seen in 86% of the pulmonary adenocarcinomas, and in 0% of the colonic adenoc arcinomas. Conversely, the cytokeratin 7-negative/cytokeratin 20-posit ive immunophenotype was seen in 77% of the colonic carcinomas, and in 0% of the pulmonary tumors. In conclusion, cytokeratin 7/cytokeratin 2 0 immunostaining patterns may be helpful in separating pulmonary adeno carcinomas from colonic adenocarcinomas.